DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
BioOrbit
United Kingdom
- London
- 01/05/2026
- Seed
- $13,334,811
BioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs. Our grand aim is to develop a pharmaceuticals factory in space within the next 10 years. We are dreaming big and making it happen. In-orbit demo early 2025.
Accelerators (most recent first)
- Airbus Accelerator Cohort 1
- Seraphim Space Accelerator Mission 12
- ESA BSGN Life Sciences
- ESA BIC UK
- UK Space Agency LEO Accelerator
If you are interested in learning more, please reach out to business@bioorbit.space
- Industry Space Research and Technology
- Website https://www.bioorbit.space/
- LinkedIn https://www.linkedin.com/company/bioorbit/
Related People
Katie King, PhDFounder
United Kingdom -
London, England
- Co-founder and CEO of BioOrbit, building a pharmaceuticals factory in microgravity to revolutionise cancer treatment. Founded Summer 2023. First in-orbit demo on the ISS 2025.
- Passionate about utilising space for the benefit of humankind
- PhD Nanomedicine (Uni of Cambridge)
- 10 years research experience
- 4 years officer cadet military training
- Private pilot in training
- Tech She Can ambassador
- Homeward Bound 8 cohort
- Innovator Award 2024 - Everywoman in Tech
- Top Female Innovator 2024 - Codex World Top 50 Innovators.
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)